GSK_ Annual_Report_2021-22

159 Notes to the Standalone Financial Statements for the year ended March 31, 2022 (b) Dividend distribution and proposed dividend ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 (i) Equity shares Final dividend for the year ended March 31, 2021 of ` 30 (March 31, 2020: ` 40) per fully paid share 508,21.81 677,62.41 (ii) Dividends not recognised at the end of the reporting period In addition to the above dividends, since year end the directors have recommended the payment of a final dividend of ` 90 per fully paid equity share (including special dividend of ` 60 per equity share) (March 31, 2021: ` 30 per fully paid equity share). 1524,73.88 508,24.63 The proposed dividend for the year ended March 31, 2022 is subject to the approval of shareholders in the ensuing annual general meeting. Note 52 : Segment Reporting An operating segment is one whose operating results are regularly reviewed by the entity’s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance. The Company has identified the Chief Operating Decision Maker as its Managing Director. The Chief Operating Decision Maker reviews performance of pharmaceutical business on an overall basis. As the Company has a single reportable segment, the segment wise disclosure requirements of Ind AS 108 on Operating Segment is not applicable. In compliance to the said standard, Entity-Wide disclosures are as under : ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 Revenues from external customers attributed to the country of domicile and attributed to all foreign countries from which the company derives revenues Revenue from the Country of Domicile- India 3209,61.60 2905,84.28 Revenue from foreign countries 7,89.27 14,63.30 Total 3217,50.87 2920,47.58 ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 Details of non current asset Non Current asset from the Country of Domicile- India 598,96.15 787,51.29 Non Current asset from foreign countries - - Total 598,96.15 787,51.29 Information about major customers The Company did not have any external revenue from a particular customer which exceeded 10% of total revenue.